MLF: Routine use of artificial intelligence in molecular leukemia diagnostics

According to the latest revision of WHO classification, leukemia is still primarily diagnosed on phenotypic features, partly relying on morphology, flow cytometry and cytogenetics. These are established methods, but unfortunately it requires experienced personnel to conduct these analyses and it has a subjective component to it.
This talk will show novel AI methods to interpret phenotypic features objectively without human supervision to diagnose leukemias and lymphomas.